( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .
Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results.
OBJECTIVE We aim ed to assess the efficacy of depot leuprolide versus danazol in the treatment of endometriosis . STUDY DESIGN A double-blind r and omized trial of 270 patients from 22 centers compared the pretreatment and posttreatment laparoscopic extent of endometriosis . Pretreatment and posttreatment endometriosis symptoms and signs were assessed with st and ardized methods . RESULTS When compared with danazol , leuprolide depot caused a more rapid and profound suppression of estradiol .  Leuprolide depot and danazol were similarly efficacious in decreasing the extent of endometriosis , as well as the pain and tenderness associated with endometriosis . CONCLUSION Depot leuprolide is an effective alternative to danazol in decreasing the extent of endometriosis and endometriosis-related pain
( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .